title: HepG2 human hepatocarcinoma cells: an experimental model for photosensitization by endogenous porphyrins.
abstract: Endogenous protoporphyrin IX (PpIX) synthesis after delta-aminolaevulinic acid (ALA) administration occurs in cancer cells in vivo; PpIX, which has a short half-life, may thus constitute a good alternative to haematoporphyrin derivative (HPD) (or Photofrin). This study assesses the ability of the human hepatocarcinoma cell line HepG2 to synthesize PpIX in vitro from exogenous ALA, and compares ALA-induced toxicity and phototoxicity with the photodynamic therapy (PDT) effects of HPD on this cell line. ALA induced a dose-dependent dark toxicity, with 79% and 66% cell survival for 50 and 100 micrograms ml-1 ALA respectively after 3 h incubation; the same treatment, followed by laser irradiation (lambda = 632 nm, 25 J cm-2), induced a dose-dependent phototoxicity, with 54% and 19% cell survival 24 h after PDT. Whatever the incubation time with ALA, a 3 h delay before light exposure was found to be optimal to reach a maximum phototoxicity. HPD induced a slight dose-dependent toxicity in HepG2 cells and a dose- and time-dependent phototoxicity ten times greater than that of ALA-PpIX PDT. After 3 h incubation of 2.5 and 5 micrograms ml-1 HPD, followed by laser irradiation (lambda = 632 nm, 25 J cm-2), cell survival was 59% and 24% respectively at 24 h. Photoproducts induced by light irradiation of porphyrins absorb light in the red spectral region at longer wavelengths than the original porphyrins. The possible enhancement of PDT effects after HepG2 cell incubation with ALA or HPD was investigated by irradiating cells successively with red light (lambda = 632 nm) and light (lambda = 650 nm)(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Physiologie, 6ème étage, Faculté de Pharmacie, Nantes, France.
authors.forename: V
authors.initials: V
authors.lastname: Vonarx-Coinsman
authors.forename: M T
authors.initials: MT
authors.lastname: Foultier
authors.forename: L X
authors.initials: LX
authors.lastname: de Brito
authors.forename: L
authors.initials: L
authors.lastname: Morlet
authors.forename: A
authors.initials: A
authors.lastname: Gouyette
authors.forename: T
authors.initials: T
authors.lastname: Patrice
mesh_terms: D000622:Aminolevulinic Acid / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000378:metabolism / Q000628:therapy*; D005434:Flow Cytometry; D006415:Hematoporphyrins / Q000494:pharmacology*; D006801:Humans; D007834:Lasers; D008954:Models, Biological; D017319:Photosensitizing Agents / Q000494:pharmacology*; D010789:Phototherapy; D011524:Protoporphyrins / Q000096:biosynthesis* / Q000502:physiology; D013778:Tetrazolium Salts / Q000378:metabolism; D013844:Thiazoles / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured
chemical_list: D006415:Hematoporphyrins; D017319:Photosensitizing Agents; D011524:Protoporphyrins; D013778:Tetrazolium Salts; D013844:Thiazoles; D000622:Aminolevulinic Acid; C028025:protoporphyrin IX; C022616:thiazolyl blue